 | • レポートコード：MRC2-11QY12559 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はリソソーム蓄積症（LSD）のグローバル市場について調査・分析したレポートです。種類別（脂質代謝異常症、糖タンパク質代謝異常症）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別リソソーム蓄積症（LSD）の競争状況、市場シェア ・世界のリソソーム蓄積症（LSD）市場：種類別市場規模 2015年-2020年（脂質代謝異常症、糖タンパク質代謝異常症） ・世界のリソソーム蓄積症（LSD）市場：種類別市場規模予測 2021年-2026年（脂質代謝異常症、糖タンパク質代謝異常症） ・世界のリソソーム蓄積症（LSD）市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界のリソソーム蓄積症（LSD）市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米のリソソーム蓄積症（LSD）市場分析：米国、カナダ ・ヨーロッパのリソソーム蓄積症（LSD）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのリソソーム蓄積症（LSD）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のリソソーム蓄積症（LSD）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのリソソーム蓄積症（LSD）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Actelion Pharmaceuticals、Amicus Therapeutics、Arena Pharmaceuticals、Astellas Pharma、Astrazeneca、Biomarin Pharmaceutical、Eli Lilly、Lexicon Pharmaceuticals、Novo Nordisk、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Disorder. Further Lipid Metabolism Disorder is categorized into Gaucher disease & Fabry disease and Glycoprotein Metabolism Disorder into Pompe disease. LSD develops mainly due to deficiency of lysosomal enzyme in the living body. A person suffering from LSD could experience problems like abnormal growth of bones, delay movement of body, deafness, blindness, dementia, respiratory problems, fatigue/weakness, bone & joint deformity, organ enlargement, lung dysfunction, severe & fatal physical & mental health deterioration.
The global LSD market is expected to grow with growing Ashkenazi (Eastern and Western Europe) population, increasing pharmaceutical R&D spending, growing disposable income, rising healthcare expenditure and accelerating economic growth. Key trends of this rare disease market includes progressing drugs under pipeline and increasing preference towards gene therapy. However, there are some factors which can hinder growth of the market including stringent regulations and limited access to patent rights.
Market Analysis and Insights: Global Lysosomal Storage Disease (LSD) Market
The global Lysosomal Storage Disease (LSD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Lysosomal Storage Disease (LSD) Scope and Market Size
Lysosomal Storage Disease (LSD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lysosomal Storage Disease (LSD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Actelion Pharmaceuticals
Amicus Therapeutics
Arena Pharmaceuticals
Astellas Pharma
Astrazeneca
Biomarin Pharmaceutical
Eli Lilly
Lexicon Pharmaceuticals
Novo Nordisk
Merck
Market segment by Type, the product can be split into
Lipid Metabolism Disorder
Glycoprotein Metabolism Disorder
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lysosomal Storage Disease (LSD) Revenue
1.4 Market by Type
1.4.1 Global Lysosomal Storage Disease (LSD) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Lipid Metabolism Disorder
1.4.3 Glycoprotein Metabolism Disorder
1.5 Market by Application
1.5.1 Global Lysosomal Storage Disease (LSD) Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Lysosomal Storage Disease (LSD) Market Perspective (2015-2026)
2.2 Global Lysosomal Storage Disease (LSD) Growth Trends by Regions
2.2.1 Lysosomal Storage Disease (LSD) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lysosomal Storage Disease (LSD) Historic Market Share by Regions (2015-2020)
2.2.3 Lysosomal Storage Disease (LSD) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lysosomal Storage Disease (LSD) Market Growth Strategy
2.3.6 Primary Interviews with Key Lysosomal Storage Disease (LSD) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Lysosomal Storage Disease (LSD) Players by Market Size
3.1.1 Global Top Lysosomal Storage Disease (LSD) Players by Revenue (2015-2020)
3.1.2 Global Lysosomal Storage Disease (LSD) Revenue Market Share by Players (2015-2020)
3.1.3 Global Lysosomal Storage Disease (LSD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lysosomal Storage Disease (LSD) Market Concentration Ratio
3.2.1 Global Lysosomal Storage Disease (LSD) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Disease (LSD) Revenue in 2019
3.3 Lysosomal Storage Disease (LSD) Key Players Head office and Area Served
3.4 Key Players Lysosomal Storage Disease (LSD) Product Solution and Service
3.5 Date of Enter into Lysosomal Storage Disease (LSD) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lysosomal Storage Disease (LSD) Historic Market Size by Type (2015-2020)
4.2 Global Lysosomal Storage Disease (LSD) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020)
5.2 Global Lysosomal Storage Disease (LSD) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lysosomal Storage Disease (LSD) Market Size (2015-2020)
6.2 Lysosomal Storage Disease (LSD) Key Players in North America (2019-2020)
6.3 North America Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020)
6.4 North America Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Lysosomal Storage Disease (LSD) Market Size (2015-2020)
7.2 Lysosomal Storage Disease (LSD) Key Players in Europe (2019-2020)
7.3 Europe Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020)
7.4 Europe Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020)
8 China
8.1 China Lysosomal Storage Disease (LSD) Market Size (2015-2020)
8.2 Lysosomal Storage Disease (LSD) Key Players in China (2019-2020)
8.3 China Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020)
8.4 China Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Lysosomal Storage Disease (LSD) Market Size (2015-2020)
9.2 Lysosomal Storage Disease (LSD) Key Players in Japan (2019-2020)
9.3 Japan Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020)
9.4 Japan Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Lysosomal Storage Disease (LSD) Market Size (2015-2020)
10.2 Lysosomal Storage Disease (LSD) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020)
10.4 Southeast Asia Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020)
11 India
11.1 India Lysosomal Storage Disease (LSD) Market Size (2015-2020)
11.2 Lysosomal Storage Disease (LSD) Key Players in India (2019-2020)
11.3 India Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020)
11.4 India Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Lysosomal Storage Disease (LSD) Market Size (2015-2020)
12.2 Lysosomal Storage Disease (LSD) Key Players in Central & South America (2019-2020)
12.3 Central & South America Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020)
12.4 Central & South America Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Actelion Pharmaceuticals
13.1.1 Actelion Pharmaceuticals Company Details
13.1.2 Actelion Pharmaceuticals Business Overview
13.1.3 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Introduction
13.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020))
13.1.5 Actelion Pharmaceuticals Recent Development
13.2 Amicus Therapeutics
13.2.1 Amicus Therapeutics Company Details
13.2.2 Amicus Therapeutics Business Overview
13.2.3 Amicus Therapeutics Lysosomal Storage Disease (LSD) Introduction
13.2.4 Amicus Therapeutics Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020)
13.2.5 Amicus Therapeutics Recent Development
13.3 Arena Pharmaceuticals
13.3.1 Arena Pharmaceuticals Company Details
13.3.2 Arena Pharmaceuticals Business Overview
13.3.3 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Introduction
13.3.4 Arena Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020)
13.3.5 Arena Pharmaceuticals Recent Development
13.4 Astellas Pharma
13.4.1 Astellas Pharma Company Details
13.4.2 Astellas Pharma Business Overview
13.4.3 Astellas Pharma Lysosomal Storage Disease (LSD) Introduction
13.4.4 Astellas Pharma Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020)
13.4.5 Astellas Pharma Recent Development
13.5 Astrazeneca
13.5.1 Astrazeneca Company Details
13.5.2 Astrazeneca Business Overview
13.5.3 Astrazeneca Lysosomal Storage Disease (LSD) Introduction
13.5.4 Astrazeneca Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020)
13.5.5 Astrazeneca Recent Development
13.6 Biomarin Pharmaceutical
13.6.1 Biomarin Pharmaceutical Company Details
13.6.2 Biomarin Pharmaceutical Business Overview
13.6.3 Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Introduction
13.6.4 Biomarin Pharmaceutical Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020)
13.6.5 Biomarin Pharmaceutical Recent Development
13.7 Eli Lilly
13.7.1 Eli Lilly Company Details
13.7.2 Eli Lilly Business Overview
13.7.3 Eli Lilly Lysosomal Storage Disease (LSD) Introduction
13.7.4 Eli Lilly Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020)
13.7.5 Eli Lilly Recent Development
13.8 Lexicon Pharmaceuticals
13.8.1 Lexicon Pharmaceuticals Company Details
13.8.2 Lexicon Pharmaceuticals Business Overview
13.8.3 Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Introduction
13.8.4 Lexicon Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020)
13.8.5 Lexicon Pharmaceuticals Recent Development
13.9 Novo Nordisk
13.9.1 Novo Nordisk Company Details
13.9.2 Novo Nordisk Business Overview
13.9.3 Novo Nordisk Lysosomal Storage Disease (LSD) Introduction
13.9.4 Novo Nordisk Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020)
13.9.5 Novo Nordisk Recent Development
13.10 Merck
13.10.1 Merck Company Details
13.10.2 Merck Business Overview
13.10.3 Merck Lysosomal Storage Disease (LSD) Introduction
13.10.4 Merck Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020)
13.10.5 Merck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Lysosomal Storage Disease (LSD) Key Market Segments
Table 2. Key Players Covered: Ranking by Lysosomal Storage Disease (LSD) Revenue
Table 3. Ranking of Global Top Lysosomal Storage Disease (LSD) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lysosomal Storage Disease (LSD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Lipid Metabolism Disorder
Table 6. Key Players of Glycoprotein Metabolism Disorder
Table 7. Global Lysosomal Storage Disease (LSD) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Lysosomal Storage Disease (LSD) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Lysosomal Storage Disease (LSD) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Lysosomal Storage Disease (LSD) Market Share by Regions (2015-2020)
Table 11. Global Lysosomal Storage Disease (LSD) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Lysosomal Storage Disease (LSD) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Lysosomal Storage Disease (LSD) Market Growth Strategy
Table 17. Main Points Interviewed from Key Lysosomal Storage Disease (LSD) Players
Table 18. Global Lysosomal Storage Disease (LSD) Revenue by Players (2015-2020) (Million US$)
Table 19. Global Lysosomal Storage Disease (LSD) Market Share by Players (2015-2020)
Table 20. Global Top Lysosomal Storage Disease (LSD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lysosomal Storage Disease (LSD) as of 2019)
Table 21. Global Lysosomal Storage Disease (LSD) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Lysosomal Storage Disease (LSD) Product Solution and Service
Table 24. Date of Enter into Lysosomal Storage Disease (LSD) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020) (Million US$)
Table 27. Global Lysosomal Storage Disease (LSD) Market Size Share by Type (2015-2020)
Table 28. Global Lysosomal Storage Disease (LSD) Revenue Market Share by Type (2021-2026)
Table 29. Global Lysosomal Storage Disease (LSD) Market Size Share by Application (2015-2020)
Table 30. Global Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020) (Million US$)
Table 31. Global Lysosomal Storage Disease (LSD) Market Size Share by Application (2021-2026)
Table 32. North America Key Players Lysosomal Storage Disease (LSD) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Lysosomal Storage Disease (LSD) Market Share (2019-2020)
Table 34. North America Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020) (Million US$)
Table 35. North America Lysosomal Storage Disease (LSD) Market Share by Type (2015-2020)
Table 36. North America Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020) (Million US$)
Table 37. North America Lysosomal Storage Disease (LSD) Market Share by Application (2015-2020)
Table 38. Europe Key Players Lysosomal Storage Disease (LSD) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Lysosomal Storage Disease (LSD) Market Share (2019-2020)
Table 40. Europe Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Lysosomal Storage Disease (LSD) Market Share by Type (2015-2020)
Table 42. Europe Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Lysosomal Storage Disease (LSD) Market Share by Application (2015-2020)
Table 44. China Key Players Lysosomal Storage Disease (LSD) Revenue (2019-2020) (Million US$)
Table 45. China Key Players Lysosomal Storage Disease (LSD) Market Share (2019-2020)
Table 46. China Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020) (Million US$)
Table 47. China Lysosomal Storage Disease (LSD) Market Share by Type (2015-2020)
Table 48. China Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020) (Million US$)
Table 49. China Lysosomal Storage Disease (LSD) Market Share by Application (2015-2020)
Table 50. Japan Key Players Lysosomal Storage Disease (LSD) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Lysosomal Storage Disease (LSD) Market Share (2019-2020)
Table 52. Japan Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Lysosomal Storage Disease (LSD) Market Share by Type (2015-2020)
Table 54. Japan Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Lysosomal Storage Disease (LSD) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Lysosomal Storage Disease (LSD) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Lysosomal Storage Disease (LSD) Market Share (2019-2020)
Table 58. Southeast Asia Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Lysosomal Storage Disease (LSD) Market Share by Type (2015-2020)
Table 60. Southeast Asia Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Lysosomal Storage Disease (LSD) Market Share by Application (2015-2020)
Table 62. India Key Players Lysosomal Storage Disease (LSD) Revenue (2019-2020) (Million US$)
Table 63. India Key Players Lysosomal Storage Disease (LSD) Market Share (2019-2020)
Table 64. India Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020) (Million US$)
Table 65. India Lysosomal Storage Disease (LSD) Market Share by Type (2015-2020)
Table 66. India Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020) (Million US$)
Table 67. India Lysosomal Storage Disease (LSD) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Lysosomal Storage Disease (LSD) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Lysosomal Storage Disease (LSD) Market Share (2019-2020)
Table 70. Central & South America Lysosomal Storage Disease (LSD) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Lysosomal Storage Disease (LSD) Market Share by Type (2015-2020)
Table 72. Central & South America Lysosomal Storage Disease (LSD) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Lysosomal Storage Disease (LSD) Market Share by Application (2015-2020)
Table 74. Actelion Pharmaceuticals Company Details
Table 75. Actelion Pharmaceuticals Business Overview
Table 76. Actelion Pharmaceuticals Product
Table 77. Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020) (Million US$)
Table 78. Actelion Pharmaceuticals Recent Development
Table 79. Amicus Therapeutics Company Details
Table 80. Amicus Therapeutics Business Overview
Table 81. Amicus Therapeutics Product
Table 82. Amicus Therapeutics Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020) (Million US$)
Table 83. Amicus Therapeutics Recent Development
Table 84. Arena Pharmaceuticals Company Details
Table 85. Arena Pharmaceuticals Business Overview
Table 86. Arena Pharmaceuticals Product
Table 87. Arena Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020) (Million US$)
Table 88. Arena Pharmaceuticals Recent Development
Table 89. Astellas Pharma Company Details
Table 90. Astellas Pharma Business Overview
Table 91. Astellas Pharma Product
Table 92. Astellas Pharma Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020) (Million US$)
Table 93. Astellas Pharma Recent Development
Table 94. Astrazeneca Company Details
Table 95. Astrazeneca Business Overview
Table 96. Astrazeneca Product
Table 97. Astrazeneca Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020) (Million US$)
Table 98. Astrazeneca Recent Development
Table 99. Biomarin Pharmaceutical Company Details
Table 100. Biomarin Pharmaceutical Business Overview
Table 101. Biomarin Pharmaceutical Product
Table 102. Biomarin Pharmaceutical Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020) (Million US$)
Table 103. Biomarin Pharmaceutical Recent Development
Table 104. Eli Lilly Company Details
Table 105. Eli Lilly Business Overview
Table 106. Eli Lilly Product
Table 107. Eli Lilly Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020) (Million US$)
Table 108. Eli Lilly Recent Development
Table 109. Lexicon Pharmaceuticals Business Overview
Table 110. Lexicon Pharmaceuticals Product
Table 111. Lexicon Pharmaceuticals Company Details
Table 112. Lexicon Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020) (Million US$)
Table 113. Lexicon Pharmaceuticals Recent Development
Table 114. Novo Nordisk Company Details
Table 115. Novo Nordisk Business Overview
Table 116. Novo Nordisk Product
Table 117. Novo Nordisk Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020) (Million US$)
Table 118. Novo Nordisk Recent Development
Table 119. Merck Company Details
Table 120. Merck Business Overview
Table 121. Merck Product
Table 122. Merck Revenue in Lysosomal Storage Disease (LSD) Business (2015-2020) (Million US$)
Table 123. Merck Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lysosomal Storage Disease (LSD) Market Share by Type: 2020 VS 2026
Figure 2. Lipid Metabolism Disorder Features
Figure 3. Glycoprotein Metabolism Disorder Features
Figure 4. Global Lysosomal Storage Disease (LSD) Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Lysosomal Storage Disease (LSD) Report Years Considered
Figure 9. Global Lysosomal Storage Disease (LSD) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Lysosomal Storage Disease (LSD) Market Share by Regions: 2020 VS 2026
Figure 11. Global Lysosomal Storage Disease (LSD) Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Lysosomal Storage Disease (LSD) Market Share by Players in 2019
Figure 14. Global Top Lysosomal Storage Disease (LSD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lysosomal Storage Disease (LSD) as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Lysosomal Storage Disease (LSD) Revenue in 2019
Figure 16. North America Lysosomal Storage Disease (LSD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Lysosomal Storage Disease (LSD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Lysosomal Storage Disease (LSD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Lysosomal Storage Disease (LSD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Lysosomal Storage Disease (LSD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Lysosomal Storage Disease (LSD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Lysosomal Storage Disease (LSD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
リソソーム蓄積症（LSD）治療薬の世界市場（～2026年） Lysosomal storage disorders is a group of genetic metabolic diseases caused by enzyme deficiencies in various body cells. The Gaucher's Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market. Market Analysis and Insights: Glob…- リソソームα-グルコシダーゼの世界市場（～2026年） Market Analysis and Insights: Global Lysosomal Alpha Glucosidase Market The global Lysosomal Alpha Glucosidase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lysosomal Alpha Glucosidase Scope and Market Size Lysosomal…
- 脂質異常症治療の世界市場（～2026年） Lipid disorder means the people high blood levels of low-density lipoprotein (LDL) cholesterol, fats called triglycerides,. Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Phar…
- アミノ酸代謝異常治療の世界市場（～2026年） Market Analysis and Insights: Global Amino Acid Metabolism Disorders Treatment Market The global Amino Acid Metabolism Disorders Treatment market size is projected to reach US$ 578.9 million by 2026, from US$ 547 million in 2020, at a CAGR of 5.3%% during 2021-2026. Global Amino Acid Metabolism Diso…
- データストレージの世界市場（～2026年） Market Analysis and Insights: Global Data Storage Market The global Data Storage market size is projected to reach US$ 50540 million by 2026, from US$ 46940 million in 2020, at a CAGR of 7.1%% during 2021-2026. Global Data Storage Scope and Market Size Data Storage market is segmented by Type, and b…